Compound: Semax Classification: Synthetic heptapeptide Amino Acid Sequence: Met-Glu-His-Phe-Pro-Gly-Pro Molecular Formula (free peptide): C₃₇H₅₁N₉O₁₀S Molecular Weight (free peptide): Approximately 813.9 g/mol Peptide Length: 7 amino acid residues Physical Form: White lyophilized powder Nominal Amount: 10MG Purity: Refer to batch-specific Certificates of Analysis Batch/Lot: Refer to corresponding analytical documentation Molecular formula and weight refer to the free peptide. The supplied salt form and any associated counterions require separate verification.

Storage: Store unopened lyophilized powder in a cool, dry place, away from direct sunlight, heat, and moisture. Handling: Keep the vial tightly sealed until laboratory use. Follow appropriate laboratory handling procedures. Batch Documentation: Refer to the Certificate of Analysis associated with the product's lot number for analytical specifications. Research Use Only: Not intended for human or veterinary use.

Semax 10MG – Synthetic Research Peptide

Semax 10MG is a synthetic heptapeptide used in laboratory research involving peptide identification, molecular characterization, and analytical testing. The compound consists of seven amino acid residues and has a defined molecular structure.

Zenith supplies Semax 10MG in white lyophilized powder form for laboratory research and analytical applications. Additionally, batch-specific Certificates of Analysis provide information about tested samples, including purity, identity, and measured content.

What Is Semax?

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH), with an additional Pro-Gly-Pro sequence. The peptide contains seven amino acid residues arranged in a linear structure. Consequently, researchers can investigate its molecular identity through established laboratory methods.

For example, liquid chromatography can help evaluate sample composition, while mass spectrometry supports molecular identification. Furthermore, researchers can compare analytical characteristics across individual production batches.

Laboratory Research Applications

Researchers may examine Semax through several analytical approaches:

• Molecular identification: Evaluate the chemical identity of the research material.
• Structural characterization: Examine the peptide’s amino acid sequence and molecular properties.
• Chromatographic analysis: Assess sample composition using laboratory separation techniques.
• Mass spectrometry: Investigate molecular identity and related analytical characteristics.
• Purity assessment: Review results documented in batch-specific Certificates of Analysis.
• Physicochemical characterization: Examine material properties under controlled laboratory conditions.

Additionally, laboratory teams can compare analytical findings between production lots. As a result, researchers can document differences in measured content and purity.

However, analytical results do not establish clinical suitability or therapeutic effectiveness.

Semax 10MG Product Specifications

• Product Name: Semax 10MG
• Classification: Synthetic heptapeptide
• Peptide Length: Seven amino acid residues
• Physical Form: White lyophilized powder
• Nominal Amount: 10MG
• Purity: Refer to batch-specific Certificates of Analysis
• Batch/Lot Information: Available in corresponding analytical documentation

Analytical Documentation

Zenith maintains laboratory documentation for tested Semax batches. These reports identify the analyzed samples and provide results for purity, physical appearance, and measured content. Because analytical results apply to specific tested samples, researchers should consult the Certificate of Analysis associated with the corresponding product lot.

Storage and Handling

Store unopened powder in a cool, dry place, away from direct sunlight, heat, and moisture. Keep the vial tightly sealed until laboratory use.

Research Use Only

Zenith supplies Semax 10MG exclusively for laboratory research and analytical applications. This product is not intended for human or veterinary use, diagnostic procedures, therapeutic administration, or clinical applications.